𝔖 Bobbio Scriptorium

✦ LIBER ✦

RE: IMMEDIATE VERSUS DEFERRED TREATMENT FOR ADVANCED PROSTATE CANCER: INITIAL RESULTS OF THE MEDICAL RESEARCH COUNCIL TRIAL (EDITORIAL COMMENT)

✍ Scribed by Kirk, David

Book ID: 122661434
Publisher: Lippincott Williams and Wilkins
Year: 1998
Tongue: English
Weight: 166 KB
Volume: 159
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(01)63284-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

RE: IMMEDIATE VERSUS DEFERRED TREATMENT

RE: IMMEDIATE VERSUS DEFERRED TREATMENT FOR ADVANCED PROSTATE CANCER: INITIAL RESULTS OF THE MEDICAL RESEARCH COUNCIL TRIAL (EDITORIAL COMMENT)

✍ Walsh, P.C. 📂 Article 📅 1998 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 213 KB

Immediate Versus Deferred Hormonal Treat

Immediate Versus Deferred Hormonal Treatment for Patients With Prostate Cancer Who are Not Suitable for Curative Local Treatment: Results of the Randomized Trial SAKK 08/88

✍ Walsh, Patrick C. 📂 Article 📅 2005 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 47 KB

Commentary on “International phase III t

Commentary on “International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: Long-term results of the BA06 30894 trial.” Griffiths G, Hall R, Sylvester R, Raghavan D, Parmar MK, and the International Collaboration of Trialists; Medical Research Council Advanced Bladder Cancer Working Party (now the National Cancer Research Institute Bladder Cancer Clinical Studies Group); European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group; Australian Bladder Cancer Study Group; National Cancer Institute of Canada Clinical Trials Group; Finnbladder; Norwegian Bladder Cancer Study Group; Club Urologico Espanol de Tratamiento Oncologico Group. Medical Research Council Clinical Trials Unit, London, United Kingdom: J Clin Oncol 2011;29:2171–7

✍ H. Barton Grossman 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Re: Fritz H. Schröder, Karl-Heinz Kurth,

Re: Fritz H. Schröder, Karl-Heinz Kurth, Sophie D. Fossa, et al. Early Versus Delayed Endocrine Treatment of T2-T3 pN1-3 M0 Prostate Cancer Without Local Treatment of the Primary Tumour: Final Results of European Organisation for the Research and Treatment of Cancer Protocol 30846 After 13 Years of Follow-up (A Randomised Controlled Trial). Eur Urol 2009;55:14–22

✍ Tomasz Drewa 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Can multiparametric magnetic resonance i

Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology?11Mohamed Abd-Alazeez receives funding from the Egyptian government. Mark Emberton and Hashim U. Ahmed receive funding from USHIFU and Advanced Medical Diagnostics for clinical trials. Mark Emberton is a paid consultant for Steba Biotech, USHIFU and Sanofi-Aventis. Mark Emberton has received research support by GSK for a study evaluating the role of MRI in men with prostate cancer. Mark Emberton and Hashim Ahmed have previously received medical consultancy fees from GE Healthcare/Oncura and Hashim Ahmed previously from Steba Biotech. Mark Emberton is a medical director of Mediwatch PLC. Hashim Uddin Ahmed and Mark Emberton receive funding from the Medical Research Council, the NIHR-HTA, NIHR-i4i, the US NIH/NCI, Pelican Cancer Foundation, Prostate Cancer UK, and St Peter׳s Trust. This work was part funded by research support for Mark Emberton and Alex Kirkham from the UK National Institute of Health Research UCLH/UCL Comprehensive Biomedical Research Centre, London, UK.

✍ Abd-Alazeez, Mohamed; Ahmed, Hashim U.; Arya, Manit; Allen, Clare; Dikaios, Niko 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 415 KB